StocktoriaBon Natural Life Ltd BON
Nasdaq · XNAS · stock · Medicinal Chemicals & Botanical Products
Chart by TradingView
3/9
Piotroski F — financial health
4.25
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $18.7M | $23.8M | $29.5M | $29.9M | $25.5M |
| Gross profit | $3.9M | $7.1M | $8.8M | $9.4M | $7.1M |
| Operating income | -$1.6M | $1.9M | $5.9M | $6.6M | $5.4M |
| Net income | -$2.0M | $398,172 | $4.6M | $6.2M | $4.6M |
| Operating cash flow | $141,115 | -$7.7M | $6.3M | -$157,125 | $4.1M |
| Free cash flow | $134,288 | -$7.7M | $6.3M | -$184,820 | $4.0M |
| Total assets | $85.2M | $61.8M | $46.6M | $37.3M | $36.4M |
| Total liabilities | $27.2M | $17.4M | $10.6M | $7.2M | $9.9M |
| Shareholders' equity | $58.0M | $44.3M | $36.0M | $30.1M | $26.5M |
| Ratios | |||||
| Gross margin | 20.8% | 29.8% | 29.9% | 31.5% | 27.9% |
| Operating margin | -8.7% | 7.9% | 20.1% | 22.1% | 21.2% |
| Net margin | -10.7% | 1.7% | 15.6% | 20.9% | 18.0% |
| FCF margin | 0.7% | -32.4% | 21.3% | -0.6% | 15.7% |
| Return on assets | -2.3% | 0.6% | 9.9% | 16.7% | 12.6% |
| Return on equity | -3.4% | 0.9% | 12.8% | 20.7% | 17.3% |
| Debt / equity | 0.01× | 0.03× | 0.04× | 0.01× | 0.08× |
| Current ratio | 1.74 | 2.42 | 2.52 | 2.21 | 2.20 |
| Revenue growth | -21.7% | -19.2% | -1.3% | 17.3% | 39.9% |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 4.25 (safe)
- Working capital / assets 0.228
- Retained earnings / assets 0.195
- EBIT / assets -0.019
- Equity / liabilities 2.133
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001816815 · as of 2025-09-30. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.